SCHEMBL14049294

SCHEMBL14049294

OCC1OC(c2cccc(CN3CCc4ccccc4C3)c2)[C@H](O)C(O)[C@@H]1O

nearest known ligand 0.58

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SLC5A2 P31639 19/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12426271 1.00 SLC5A2 (0.58) SLC5A2
SCHEMBL14544885 0.91 SLC5A2 (0.47) SLC5A2
SCHEMBL1670098 0.79 SLC5A2 (0.73) SLC5A2
SCHEMBL29657531 0.79 SLC5A2 (0.73) SLC5A2
SCHEMBL14049183 0.76 SLC5A2 (0.66) SLC5A2
SCHEMBL1854627 0.76 SLC5A2 (0.66) SLC5A2
SCHEMBL17480493 0.76 SLC5A2 (0.66) SLC5A2
SCHEMBL12661914 0.76 SLC5A2 (0.66) SLC5A2
SCHEMBL20140056 0.75 SLC5A2 (0.73) SLC5A2
SCHEMBL14049032 0.75 SLC5A2 (0.65) SLC5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1980560-A2 C-glycoside derivatives for the treatment of diabetes Astellas Pharma Inc. (JP) 2008-10-15 EP disclosed